Status:
UNKNOWN
Cardiometabolic Effects of Rapid Glucose Excursion
Lead Sponsor:
Barmherzige Brüder Linz
Conditions:
Diabetes Mellitus, Experimental
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The effects of rapid glucose excursions, induced by intravenous bolus application of glucose in healthy probands, on cardiometabolic and inflammatory parameters will be investigated
Detailed Description
BACKGROUND: It is well known that people with diabetes have a five times higher risk of dying of cardiovascular death than non-diabetics. However not only hyperglycaemia per se but also glycaemic vari...
Eligibility Criteria
Inclusion
- Men aged 18 years or older with no disease history
- written informed consent
Exclusion
- receiving any medication
- probands who suffer from infectious disease
Key Trial Info
Start Date :
April 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04488848
Start Date
April 11 2019
End Date
July 1 2021
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barmherzige Brüder Linz - Innere Medizin
Linz, Austria, 4021